Marketwatch Biocon jumps 4% on launch of drug Fulphila in Canada Admin April 29, 2020 Biocon has shared or co-exclusive commercialisation rights with Mylan for the product in the rest of the world. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
